Trulieve Cannabis (CNSX:TRUL) Rises 11.5% Following Acquisition of Conditional Medical Cannabis License in Texas - What’s New?

Written by Emily J. Thompson, Senior Investment Analyst

Source: Yahoo Finance

Updated: Dec 06 2025

0mins

Source: Yahoo Finance

Trulieve's Texas License Approval: Trulieve Cannabis Corp. received conditional approval for a Dispensing Organization license in Texas, allowing it to cultivate, manufacture, and distribute medical cannabis products, which could enhance its growth potential in a significant market.
Investment Outlook and Risks: While the Texas license offers a new growth avenue, Trulieve's future performance remains tied to federal policy changes and tax reforms, with current challenges including ongoing losses and margin pressures.
Revenue Projections: Trulieve aims for $1.2 billion in revenue and $15 million in earnings by 2028, necessitating modest annual growth and significant earnings recovery from current losses.
Diverse Fair Value Estimates: The community's fair value estimates for Trulieve's stock vary widely, indicating differing opinions on its worth, emphasizing the importance of considering multiple perspectives before investing.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.